These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

77 related items for PubMed ID: 10428759

  • 1. Substitution of the insulin receptor transmembrane domain with that of glycophorin A inhibits insulin action.
    Gardin A, Auzan C, Clauser E, Malherbe T, Aunis D, Crémel G, Hubert P.
    FASEB J; 1999 Aug; 13(11):1347-57. PubMed ID: 10428759
    [Abstract] [Full Text] [Related]

  • 2. Optimizing transmembrane domain helicity accelerates insulin receptor internalization and lateral mobility.
    Goncalves E, Yamada K, Thatte HS, Backer JM, Golan DE, Kahn CR, Shoelson SE.
    Proc Natl Acad Sci U S A; 1993 Jun 15; 90(12):5762-6. PubMed ID: 8390680
    [Abstract] [Full Text] [Related]

  • 3. Substitution of the insulin receptor transmembrane domain with the c-neu/erbB2 transmembrane domain constitutively activates the insulin receptor kinase in vitro.
    Yamada K, Goncalves E, Kahn CR, Shoelson SE.
    J Biol Chem; 1992 Jun 25; 267(18):12452-61. PubMed ID: 1352286
    [Abstract] [Full Text] [Related]

  • 4. Substitution of the erbB-2 oncoprotein transmembrane domain activates the insulin receptor and modulates the action of insulin and insulin-receptor substrate 1.
    Cheatham B, Shoelson SE, Yamada K, Goncalves E, Kahn CR.
    Proc Natl Acad Sci U S A; 1993 Aug 01; 90(15):7336-40. PubMed ID: 7688476
    [Abstract] [Full Text] [Related]

  • 5. Two sequences flanking the major autophosphorylation site of the insulin receptor are essential for tyrosine kinase activation.
    Leconte I, Clauser E.
    Biochem J; 1995 Mar 01; 306 ( Pt 2)(Pt 2):465-72. PubMed ID: 7887900
    [Abstract] [Full Text] [Related]

  • 6. Role of the transmembrane domain and flanking amino acids in internalization and down-regulation of the insulin receptor.
    Yamada K, Carpentier JL, Cheatham B, Goncalves E, Shoelson SE, Kahn CR.
    J Biol Chem; 1995 Feb 17; 270(7):3115-22. PubMed ID: 7852393
    [Abstract] [Full Text] [Related]

  • 7. Transmembrane domain inversion blocks ER release and insulin receptor signaling.
    Yamada K, Goncalves E, Carpentier JL, Kahn CR, Shoelson SE.
    Biochemistry; 1995 Jan 24; 34(3):946-54. PubMed ID: 7827053
    [Abstract] [Full Text] [Related]

  • 8. Dimerisation of the glycophorin A transmembrane segment in membranes probed with the ToxR transcription activator.
    Langosch D, Brosig B, Kolmar H, Fritz HJ.
    J Mol Biol; 1996 Nov 08; 263(4):525-30. PubMed ID: 8918935
    [Abstract] [Full Text] [Related]

  • 9. Modulation of insulin signal transduction by eutopic overexpression of the receptor-type protein-tyrosine phosphatase LAR.
    Zhang WR, Li PM, Oswald MA, Goldstein BJ.
    Mol Endocrinol; 1996 May 08; 10(5):575-84. PubMed ID: 8732688
    [Abstract] [Full Text] [Related]

  • 10. Insulin internalization in the absence of the insulin receptor tyrosine kinase domain is insufficient for mediating intracellular biological effects.
    Schranz DB, Rohilla AM, Anderson C, Wood WM, Berhanu P.
    Biochem Biophys Res Commun; 1996 Oct 14; 227(2):600-7. PubMed ID: 8878559
    [Abstract] [Full Text] [Related]

  • 11. The C-terminal third of the human luteinizing hormone (LH) receptor is important for inositol phosphate release: analysis using chimeric human LH/follicle-stimulating hormone receptors.
    Hirsch B, Kudo M, Naro F, Conti M, Hsueh AJ.
    Mol Endocrinol; 1996 Sep 14; 10(9):1127-37. PubMed ID: 8885247
    [Abstract] [Full Text] [Related]

  • 12. Insulin receptor activation with transmembrane domain ligands.
    Lee J, Miyazaki M, Romeo GR, Shoelson SE.
    J Biol Chem; 2014 Jul 11; 289(28):19769-77. PubMed ID: 24867955
    [Abstract] [Full Text] [Related]

  • 13. Activation of glucose transport by a natural mutation in the human insulin receptor.
    Longo N, Langley SD, Griffin LD, Elsas LJ.
    Proc Natl Acad Sci U S A; 1993 Jan 01; 90(1):60-4. PubMed ID: 8419945
    [Abstract] [Full Text] [Related]

  • 14. Evidence supporting a passive role for the insulin receptor transmembrane domain in insulin-dependent signal transduction.
    Frattali AL, Treadway JL, Pessin JE.
    J Biol Chem; 1991 May 25; 266(15):9829-34. PubMed ID: 2033070
    [Abstract] [Full Text] [Related]

  • 15. An arginine to cysteine(252) mutation in insulin receptors from a patient with severe insulin resistance inhibits receptor internalisation but preserves signalling events.
    Hamer I, Foti M, Emkey R, Cordier-Bussat M, Philippe J, De Meyts P, Maeder C, Kahn CR, Carpentier JL.
    Diabetologia; 2002 May 25; 45(5):657-67. PubMed ID: 12107746
    [Abstract] [Full Text] [Related]

  • 16. Mutagenic structure/function analysis of the cytoplasmic cysteines of the insulin receptor.
    Macaulay SL, Polites M, Frenkel MJ, Hewish DR, Ward CW.
    Biochem J; 1995 Mar 15; 306 ( Pt 3)(Pt 3):811-20. PubMed ID: 7702578
    [Abstract] [Full Text] [Related]

  • 17. Light-driven activation of beta 2-adrenergic receptor signaling by a chimeric rhodopsin containing the beta 2-adrenergic receptor cytoplasmic loops.
    Kim JM, Hwa J, Garriga P, Reeves PJ, RajBhandary UL, Khorana HG.
    Biochemistry; 2005 Feb 22; 44(7):2284-92. PubMed ID: 15709741
    [Abstract] [Full Text] [Related]

  • 18. Two steps of insulin receptor internalization depend on different domains of the beta-subunit.
    Carpentier JL, Paccaud JP, Backer J, Gilbert A, Orci L, Kahn CR, Baecker J [corrected to Backer J].
    J Cell Biol; 1993 Sep 22; 122(6):1243-52. PubMed ID: 8376461
    [Abstract] [Full Text] [Related]

  • 19. A molecular biologic approach to study the fine specificity of antibodies directed to the MN human blood group antigens.
    Blackall DP, Ugorski M, Påhlsson P, Shakin-Eshleman SH, Spitalnik SL.
    J Immunol; 1994 Mar 01; 152(5):2241-7. PubMed ID: 8133037
    [Abstract] [Full Text] [Related]

  • 20. Insulin inhibition of protein degradation in cells expressing wild-type and mutant insulin receptors.
    Hamel FG, Fawcett J, Andersen CI, Berhanu P, Bennett RG, Duckworth WC.
    J Endocrinol Invest; 2003 Nov 01; 26(11):1088-94. PubMed ID: 15008246
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.